Michael Scheffler from QIAGEN discusses how evolving sample preparation technologies are driving reproducibility and efficiency in modern laboratories.
color = "#939598";.pullquote_left1, .pullquote_right1, .pullquote_left, .pullquote_right { color: #FEF8F6; background: #939598 } .breakhead { color: #000000; border-bottom: 1px solid #000000; } SPONSOR PROFILE About QIAGEN It all starts with the sample. Genetic material must be extracted from a biological sample and specifically processed before scientists from academia and industry can actually work with it. QIAGEN has made the hand
Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector manufacturing.
Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.
Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.
Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development
Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
